• No recruitment challenges: Largely untapped patient pool of over one billion people
• Underutilized, treatment naive population with very diverse genetic backgrounds
• Motivated and qualified medical personnel
• Regionalization of approval process
• Population with first and third world diseases
• Population with unique life sciences profile that will translate well for submissions in the USA, EU and rest of the World
• Significant cost and time savings; Cost effective study sites
• Proximity to Europe and North America, closer to North America and Europe than Asia
• The market potential of approved drugs

---

The Guosa Life Sciences Advantage

• We speak the languages
• We understand the cultural attitudes and behaviors that may impact the success of your drug development program
• We have experiences in several therapeutic areas
• We have strategic alliances and relationships with trained local resources and institutions
• Uncompromising commitment to patient safety and success of customer studies
• Unparalleled commitment to Integrity, Quality and Ethics
• We have a global presence, and a strong ability to deliver services across borders

---

Below is list of regulatory guidance for conducting clinical trials in the following countries: